Previous studies have shown that LMO1 is involved in T-cell Acute Lymphoblastic Leukemia (T-ALL) and neuroblastoma, and its role in BC, particularly in the TCGA Cluster 5, supports its potential as a marker for aggressive cancer phenotypes. Here, LMO1 is linked to acute lymphoblastic leukemia.